SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 297 filers reported holding SEATTLE GENETICS INC in Q2 2018. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $169,571,000 | +79886.3% | 866,529 | +72110.8% | 0.08% | – |
Q2 2020 | $212,000 | -98.2% | 1,200 | -99.3% | 0.00% | -100.0% |
Q1 2019 | $11,967,000 | +29.3% | 163,400 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $9,258,000 | -26.5% | 163,400 | 0.0% | 0.01% | 0.0% |
Q3 2018 | $12,601,000 | +75.1% | 163,400 | +50.7% | 0.01% | +50.0% |
Q2 2018 | $7,197,000 | +26.8% | 108,400 | 0.0% | 0.00% | +33.3% |
Q1 2018 | $5,674,000 | +3.6% | 108,400 | +5.9% | 0.00% | 0.0% |
Q4 2017 | $5,478,000 | +25.8% | 102,400 | +28.0% | 0.00% | +50.0% |
Q3 2017 | $4,353,000 | +88.7% | 80,000 | +118.0% | 0.00% | +100.0% |
Q1 2017 | $2,307,000 | -80.9% | 36,699 | -86.7% | 0.00% | -83.3% |
Q3 2013 | $12,054,000 | +25.0% | 275,030 | -10.3% | 0.01% | 0.0% |
Q2 2013 | $9,644,000 | – | 306,530 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |